GILEAD SCIENCES, INC. - 8-K Filing
Gilead Sciences issued $3 billion in senior notes (4.250% due 2028, 4.400% due 2029, 4.600% due 2031, and 4.900% due 2034) through a public offering underwritten by Barclays Capital Inc., BofA Securities, Inc., and Citigroup Global Markets Inc. The notes were sold at discounts ranging from 99.567% to 99.758% of face value plus accrued interest. Proceeds will be used for general corporate purposes including acquisitions or strategic transactions. (Items: 1.01 Entry into a Material Definitive Agreement, 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, 8.01 Other Information, 9.01 Financial Statements and Exhibits)
Tickers: $GILD